Company / R&D per Share
Harmony Biosciences Holdings, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.32
FY2025
5-year range
$1.21 / $3.32
FY2021-FY2025
Trend
+29.2%
vs FY2024
Sector context
#65 of 208
Health Care
What the data says
At $3.32, Harmony Biosciences Holdings, Inc.'s r&d per share ranks #65 of 208 in the Health Care sector. R&D per Share has increased for 3 consecutive years, from $1.21 in FY2022 to $3.32 in FY2025.
Based on SEC 10-K filings.
3.32 in FY2025 with a 5-year CAGR of -18.0%.
Improved from $1.28 to $3.32 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +40.2%
- 5-Year CAGR
- -18.0%
- 10-Year CAGR
- -
Sector benchmark
#65 of 208 in Health CareTop 31% of 208This company $3.32 Sector average $12.19
▼
-72.8% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 29.2% year-over-year.
- Ranks #65 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.32 | +29.2% |
| FY2024 | $2.57 | +101.3% |
| FY2023 | $1.28 | +5.9% |
| FY2022 | $1.21 | -1.5% |
| FY2021 | $1.22 | -86.3% |
| FY2020 | $8.94 | -0.1% |
| FY2019 | $8.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026